- Home
- NTB vs TNDM Comparison
NTB vs TNDM Comparison
Compare NTB & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTB
- TNDM
- Stock Information
- Founded
- NTB 1858
- TNDM 2006
- Country
- NTB Bermuda
- TNDM United States
- Employees
- NTB N/A
- TNDM N/A
- Industry
- NTB Commercial Banks
- TNDM Medical/Dental Instruments
- Sector
- NTB Finance
- TNDM Health Care
- Exchange
- NTB Nasdaq
- TNDM Nasdaq
- Market Cap
- NTB 1.7B
- TNDM 1.9B
- IPO Year
- NTB 2016
- TNDM 2013
- Fundamental
- Price
- NTB $37.51
- TNDM $33.98
- Analyst Decision
- NTB Buy
- TNDM Buy
- Analyst Count
- NTB 6
- TNDM 16
- Target Price
- NTB $39.67
- TNDM $52.06
- AVG Volume (30 Days)
- NTB 171.9K
- TNDM 1.3M
- Earning Date
- NTB 02-10-2025
- TNDM 11-06-2024
- Dividend Yield
- NTB 4.67%
- TNDM N/A
- EPS Growth
- NTB N/A
- TNDM N/A
- EPS
- NTB 4.50
- TNDM N/A
- Revenue
- NTB $573,100,000.00
- TNDM $854,351,000.00
- Revenue This Year
- NTB N/A
- TNDM $23.98
- Revenue Next Year
- NTB N/A
- TNDM $10.89
- P/E Ratio
- NTB $8.45
- TNDM N/A
- Revenue Growth
- NTB N/A
- TNDM 10.75
- 52 Week Low
- NTB $28.73
- TNDM $21.85
- 52 Week High
- NTB $40.55
- TNDM $53.69
- Technical
- Relative Strength Index (RSI)
- NTB 48.52
- TNDM 54.54
- Support Level
- NTB $37.21
- TNDM $31.89
- Resistance Level
- NTB $38.33
- TNDM $34.43
- Average True Range (ATR)
- NTB 0.74
- TNDM 1.60
- MACD
- NTB -0.00
- TNDM 0.40
- Stochastic Oscillator
- NTB 43.38
- TNDM 77.17
About NTB Bank of N.T. Butterfield & Son Limited (The) Voting
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, the Cayman Islands, the Channel Islands, and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.